These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
925 related articles for article (PubMed ID: 15671273)
1. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Ottino P; He J; Axelrad TW; Bazan HE Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273 [TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Tao Y; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. Ottino P; Taheri F; Bazan HE Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920 [TBL] [Abstract][Full Text] [Related]
4. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus). Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196 [TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
6. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Jo M; Thomas LE; Wheeler SE; Curry TE Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206 [TBL] [Abstract][Full Text] [Related]
7. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
8. Increased expression and cell surface localization of MT1-MMP plays a role in stimulation of MMP-2 activity by leptin in neonatal rat cardiac myofibroblasts. Schram K; Wong MM; Palanivel R; No EK; Dixon IM; Sweeney G J Mol Cell Cardiol; 2008 May; 44(5):874-81. PubMed ID: 18436234 [TBL] [Abstract][Full Text] [Related]
9. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y; Yeon J; Kim HJ; Lee ST Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [TBL] [Abstract][Full Text] [Related]
11. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells. Luo XH; Liao EY Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673 [TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. He J; Bazan HE Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020 [TBL] [Abstract][Full Text] [Related]
14. Paradigmatic identification of MMP-2 and MT1-MMP activation systems in cardiac fibroblasts cultured as a monolayer. Guo C; Jiang J; Elliott JM; Piacentini L J Cell Biochem; 2005 Feb; 94(3):446-59. PubMed ID: 15534869 [TBL] [Abstract][Full Text] [Related]
15. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. Ma X; Bazan HE Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1696-702. PubMed ID: 10845588 [TBL] [Abstract][Full Text] [Related]
16. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. Andrian E; Mostefaoui Y; Rouabhia M; Grenier D J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791 [TBL] [Abstract][Full Text] [Related]
17. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029 [TBL] [Abstract][Full Text] [Related]
18. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses. Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Ohnishi K; Takagi M; Kurokawa Y; Satomi S; Konttinen YT Lab Invest; 1998 Sep; 78(9):1077-87. PubMed ID: 9759652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]